FABP4 and breast carcinoma: Given the established link between obesity-associated lipid dysregulation increased breast cancer risk [27, 28], FABP4 and FABP5 play critical roles in facilitating fatty acid oxidation and metabolism, as well as promoting oncogenic lipid signaling pathways.